This page is dedicated to the Childhood-onset Systemic Lupus Erythematosus (cSLE) research study, one of over 60 studies supported by the Boston Children’s Rare Disease Collaborative (CRDC). For more information about the CRDC, please visit our home page. Established in 2018, the CRDC supports pediatric rare disease research and provides families with genetic diagnoses that enable personalized treatments, including precision medicine and targeted therapies.
Joyce Chang, MD, MSCE
Associate Professor, Harvard Medical School
Attending Physician, Rheumatology Program
The Childhood-onset Systemic Lupus Erythematosus (cSLE) research study was established in 2025 and is led by Dr. Joyce Chang.